GlaxoSmithKline announced that alli (orlistat) capsules have returned to most stores in the United States and Puerto Rico following the voluntary recall in March 2014.
Pregnant women with various classes of obesity should not gain any weight until mid-pregnancy or later for optimal pregnancy outcomes, according to a new study in the journal Obesity.
Nurture, not nature, may play a greater role in childhood obesity as researchers have found that environment may be an equal (if not stronger) force in determining obesity compared to the mother's diet.
Compared to healthy individuals, women with multiple sclerosis (MS) may have lower levels of key antioxidant and anti-inflammatory nutrients such as folate and vitamin E.
The U.S. Department of Health and Human Services (HHS) has announced that the 2015 Dietary Guidelines Advisory Committee (DGAC) has submitted recommendations to HHS Secretary Sylvia M. Burwell and Agriculture Secretary Tom Vilsack for the 2015 edition of the Dietary Guidelines for Americans.
New research published in The Journal of Pediatrics suggests that a plant-based, low-fat vegan diet can significantly reduce risk factors for cardiovascular disease in obese children.
Genzyme announced results from its extension study of the Phase 3 ENGAGE and ENCORE studies of Cerdelga (eliglustat) for the treatment of certain adults with Gaucher disease type 1.
Increased cranberry juice consumption has been linked to lower levels of C-reactive protein (CRP), a marker of inflammation.
Iron supplementation, compared to no supplementation, significantly reduced time to recovery of lost iron and hemoglobin after a blood donation, according to a new study.
Detox Transforms Health and Nutrition announced a voluntary recall of 5 dietary supplements after they were found to contain undeclared drug ingredients.
Advanced Inhalation Therapies announced that the Food and Drug Administration (FDA) has granted Orphan Drug designation to AIT-CF, a high dose formulation of nitric oxide for adjunctive treatment of cystic fibrosis (CF).
New York Attorney General Eric T. Schneiderman has requested that four major retailers in New York cease sales of certain store brand herbal supplements after the presence of the labeled substance could not be verified or the supplements were found to contain ingredients not listed on the labels.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Yanhee Slim, a dietary supplement promoted for weight loss.
Super Bowl Sunday is reported to be the second biggest food day for Americans after Thanksgiving, with the average American consuming as much as 2,400 calories during the game.
A new international collaboration published in The Lancet Psychiatry is encouraging the fields of psychiatry and public health to recognize the relationships between diet quality, potential nutritional deficiencies, and mental health.
A new oral therapy that combines a probiotic and peanut protein appears to be a successful immunotherapy for peanut allergy, based on a study conducted by researchers at Murdoch Childrens Research Institute at the Royal Children's Hospital in Australia.
Hospira announced a voluntary recall of one lot of 0.9% Sodium Chloride Injection due to particulate matter sealed in the bag at the additive port area. The particulate matter was identified as a human hair.
The Food and Drug Administration (FDA) is advising consumers to not buy or use Happy Passengers, a product promoted and sold for sexual enhancement.
New research by the Centers for Disease Control and Prevention (CDC) supports the protective effect of folic acid supplementation against recurrent neural tube defects (NTD).
The Endocrine Society has issued a Clinical Practice Guideline (CPG) on pharmacological strategies for managing obesity and promoting weight loss.
Brown adipose tissue was successfully activated and energy expenditure increased in 12 lean adult men treated with mirabegron in a new study.
The Food and Drug Administration (FDA) has approved EnteroMedics' VBLOC vagal blocking therapy, delivered via the Maestro System, which is the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunger and fullness.
New research in the Journal of the American Heart Association suggests that inclusion of one avocado per day as part of a moderate-fat diet may help to improve specific blood lipid markers compared to an energy-matched moderate-fat diet without avocado or a low-fat diet with avocado.
Researchers at the Salk Institute for Biological Studies have developed a compound that targets the farnesoid X receptor (FXR) in the intestines and may help to reduce diet-induced weight gain, body-wide inflammation, and hepatic glucose production while enhancing thermogenesis and browning of white adipose tissue (WAT).
Vertex announced that the FDA has approved the use of Kalydeco (ivacaftor) in patients with cystic fibrosis (CF) ages 6 years and older who have the R117H mutation in the CFTR gene.
Novo Nordisk announced that the FDA has approved Saxenda (liraglutide [rDNA origin]) injection for chronic weight management.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Slim-K, a product marketed for weight loss.
Bethel Nutritional Consulting announced a voluntary recall of B-Lipo Capsules, an herbal supplement marketed for weight loss.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to Translarna (ataluren) for the treatment of patients with Mucopolysaccharidosis I (MPS I).
In a new study published in the Journal of the American Medical Association, diets with low glycemic index of dietary carbohydrate do not appear to lead to a reduction in cardiovascular disease risk or improvement in insulin sensitivity.
Baxter announced a voluntary recall of two lots of 0.9% Sodium Chloride Injection due to particulate matter found in the solution. The particulate matter was identified as a fragment of the frangible from the vial adapter.
The Food and Drug Administration (FDA) has issued a warning regarding the risks associated with the use of dietary supplements containing live bacteria or yeast in immunocompromised persons following the death of a premature infant administered the dietary supplement ABC Dophilus Powder (Solgar), which is formulated to contain three species of live bacteria.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Slim-Vie, a supplement marketed for weight loss.
As required by the 2010 Patient Protection and Affordable Care Act, the FDA finalized that calorie information be listed on menus and menu boards in chain restaurants, similar retail food establishments, and vending machines with 20 or more locations.
The Food and Drug Administration (FDA) is warning consumers not to buy or use "Feng Shi Ling," a product marketed as an herbal drug for pain due to rheumatoid arthritis and osteoporosis.
REFA Enterprises, LLC announced a voluntary recall of Forever Beautiful Bee Pollen and Forever Beautiful Infinity products after they were found to contain undeclared ingredients. Both products are marketed as dietary supplements for weight loss.
According to research presented at the American Heart Association's Scientific Sessions 2014, adults whose mothers were overweight or obese pre-pregnancy may have a significantly increased risk of dying from heart disease or stroke.
New research presented at the American Heart Association's Scientific Session 2014 shows that high trans fat consumption is associated with worse memory among working-age men.
Patients with chronic obstructive pulmonary disease (COPD) aged ≥65 years who received nutrition treatment had reduced lengths of stay, hospital costs, and probability of readmission within 30-days, according to results of a study published in CHEST.
Solgar announced a voluntary recall of ABC Dophilus Powder due to the discovery of Rhizopus oryzae, which may cause Mucormycosis.
The Food and Drug Administration (FDA) is warning consumers not to buy or use Mayhem, a dietary supplement marketed to increase appetite and muscle growth after it was found to contain an undeclared corticosteroid and antihistamine.
Vertex announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for the combination product lumacaftor and ivacaftor for people with cystic fibrosis (CF) ages ≥12 who have two copies of the F508del mutation in the cystic fibrosis transmembrance conductance regulator (CFTR) gene.
The Food and Drug Administration (FDA) is warning consumers to not buy or use V26 Slimming Coffee, a product sold for weight loss.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to Glassia (alpha1-proteinase inhibitor [human]) for the treatment of Graft-versus-host disease (GVHD).
Takeda and Orexigen announced that Contrave (naltrexone HCl and bupropion HCl) extended-release tablets are now available by prescription.
Hospira announced a voluntary recall of various lots of several intravenous (IV) solutions in its LifeCare line due to potential for leakage.
The conversion of white adipose tissue (WAT) to beige fat as a biological response to cold temperatures may be hindered in overweight individuals, according to a new study published online in the Journal of Clinical Endocrinology & Metabolism.
The Food and Drug Administration (FDA) is advising consumers to not buy or use Sit and Slim II, a product promoted and sold for weight loss.
The United States Marshals seized over 25,000 pounds of raw kratom material valued at more than $5 million from Rosefield Mangement, Inc. in Van Nuys, CA.
The American Association of Clinical Endocrinologist (AACE) and the American College of Endocrinology (ACE) announced the publication of its position statement that describes its framework for a new diagnosis of obesity as a chronic disease.
Baxter announced a voluntary recall of one lot of Potassium Chloride Injection 10mEq/100mL at the hospital/pharmacy/nurse level.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to Lynovex (NM001; NovaBiotics) for the treatment of cystic fibrosis (CF).
The Food and Drug Administration (FDA) is warning consumers that several products promoted and sold for weight loss have been found to contain undeclared ingredients and should not be purchased or used.
The Food and Drug Administration (FDA) has accepted for filing Shire's supplemental New Drug Application (sNDA) with priority review for Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) for the treatment of adults with binge eating disorder (BED).
A Food and Drug Administration (FDA) Advisory Committee has voted in favor of recommending liraglutide for chronic weight management in individuals with obesity or who are overweight with at least one weight-related comorbidity
Takeda and Orexigen announced that the Food and Drug Administration (FDA) has approved Contrave (naltrexone HCl and bupropion HCl) extended-release tablets as adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults
Over 90% of school-age children in the United States are consuming more than the recommended daily allowance of sodium, with 10 common food types contributing to over 40% of the total sodium consumed by children, according to the Centers for Disease Control and Prevention (CDC).
Obese adults may be more susceptible to environmental food cues than lean adults due to differences in brain chemistry that make eating more habitual and less rewarding, according a new study.
Regular consumption of mango by obese adults may lower blood sugar levels without a negative impact on body weight, a recent study suggests.
Prolacta Bioscience announced the launch of Prolact RTF, the first ready-to-feed (RTF) human milk-derived premature infant formula.
Regeneca Worldwide announced the expansion of its voluntary nationwide recall of RegeneSlim appetite control dietary supplements to include four additional lots.
Pfizer and Protalix BioTherapeutics announced that the Food and Drug Administration (FDA) has approved Elelyso (taliglucerase alfa) for injection for pediatric patients.
Fresenius Kabi announced the Food and Drug Administration has approved Kabiven and Perikabiven in a 3-chamber bag.
Genzyme announced that the Food and Drug Administration (FDA) has approved Cerdelga (eliglustat) capsules for the treatment of certain adult Gaucher disease type 1 patients.
Antibiotic exposure during a critical window of early development alters the gut microbes and permanently reprograms the body's metabolism, which may increase one's susceptibility to obesity.
The Food and Drug Administration (FDA) has issued an alert regarding an ingredient commonly found in gluten-free products that may cause anaphylaxis in patients with a legume allergy.
The Food and Drug Administration (FDA) is warning consumers not to purchase or use products sold online claiming to prevent or treat the Ebola virus.
B. Braun Medical Inc. announced that the FDA has approved Nutrilipid 20% (IV fat emulsion) for parenteral nutrition therapy in adult and pediatric patients.
The Food and Drug Administration (FDA) is advising consumers to not buy or use Arize and Herbal Vigor Quick Fix, products marketed for sexual enhancement.
Regeneca announced a voluntary nationwide recall of its RegenESlim appetite control dietary supplement.
The FDA published a new regulation to provide a uniform definition of the term "gluten-free" for voluntary food labeling to help those who have celiac disease.
The FDA announced the approval of Lumizyme (alglucosidase alfa; Genzyme) for the treatment of all patients with infantile-onset Pompe disease.
A new Similac breastfeeding supplement is specially designed to enhance the levels of DHA, lutein, and vitamin E in breastmilk.
Reports of lifetime use of synthetic human growth hormone (hGH) without a prescription has more than doubled since 2012 among teens, while alcohol consumption has significantly decreased and marijuana use has remained steady, states a new study from the Partnership for Drug-Free Kids.
The FDA is warning consumers not to purchase or use O.M.G., a product marketed for sexual enhancement.
The FedEx Corporation has been indicted with charges relating to conspiracies with two separate but related online pharmacy organizations to distribute misbranded prescription drugs and controlled substances to U.S. consumers without requiring a valid prescription.
Libertas Pharma announced the launch of Multivitamins with A, B, D, E and K plus Zinc in three different formulations for patients with malabsorptive conditions, including cystic fibrosis.
Baxter announced a voluntary recall of one lot of highly concentrated Potassium Chloride Injection 20mEq/50mL in a ViaFlex Container and three lots of 0.9% Sodium Chloride Injection due to particulate matter, found in the solutions.
The FDA is warning consumers to not buy or use 6 supplements that are promoted for weight loss.
Adults with extreme obesity have increased risks of dying at a young age from cancer and other conditions, including heart disease, stroke, diabetes, and kidney and liver diseases, according to results of a pooled analysis.
The FDA is alerting healthcare professionals not to use injectable vitamin products distributed by Medical Supply Liquidators LLC in Clive, IA, with "Sunshine Labs" on the label.
Doctor's Best announced a voluntary nationwide recall of over 7,000 bottles of Red Yeast Rice dietary supplements 600mg capsules used to lower cholesterol.
Vertex announced results from two Phase 3 studies of lumacaftor in combination with ivacaftor in patients with cystic fibrosis (CF) who have two copies of F508del mutation in the CFTR gene.
The owner and CEO of Balanced Health Products (BHP) has been sentenced by a U.S. magistrate judge in Manhattan federal court to a $60,000 penalty for distributing dietary supplements that contained a prescription drug.
Consider the evidence base and recommend probiotics on a case-by-case basis.
Two studies presented at 2014 American Diabetes Association Scientific Sessions found that adults living in areas with greater walkability had a lower risk of developing diabetes over a 10-year period and that walkable neighborhoods have the lowest incidence of obesity, overweight, and diabetes.
The FDA is advising consumers not to buy or use the product Toxin Discharged Tea, a product promoted and sold for weight loss due to an undeclared ingredient.
The FDA is advising consumers to not purchase or use Gold Vigra, a product marketed and sold for sexual enhancement.
Two studies presented at the 2014 American Diabetes Association Scientific Sessions highlight the relationship between children's consumption of sugary beverages and neurological reactions, as well as changes to fat cell composition in obese children.
LipoScience, Inc. announced data on their nuclear magnetic resonance (NMR)-based diagnostic test to identify normal-weight individuals at high risk of developing type 2 diabetes.
New clinical guidelines on the diagnosis and management of idiosyncratic drug-induced liver injury (DILI) have been issued by the American College of Gastroenterology, which include a focus on herbal and dietary supplements
A study presented at the 2014 American Diabetes Association Scientific Session reported that improving the overall quality of one's diet helps to prevent type 2 diabetes apart from other lifestyle changes.
At the 2014 American Diabetes Association Scientific Sessions, GI Dynamics presented study findings that demonstrated the acute effects of EndoBarrier Therapy on glycemic control as well as data that help explain its potential mechanism of action.
Obese patients with rheumatoid arthritis (RA) have higher disease activity scores (DAS) than non-obese patients, regardless of their disease stage, scientists presented at EULAR 2014.
Strativa announced that the FDA has approved Nascobal (cyanocobalamin) Nasal Spray for the maintenance of normal hematologic status in pernicious anemia patients who are in remission following intramuscular vitamin B12 therapy and who have no nervous system involvement.
The Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) issued draft updated advice regarding the consumption of fish by pregnant and breastfeeding women and young children.
The FDA is advising consumers not to buy the product B-Perfect, promoted and sold for weight loss, after a laboratory analysis discovered undeclared sibutramine and phenolphthalein.
The FDA is warning consumers that several products promoted and sold for sexual enhancement have been found to contain undeclared ingredients and should not be purchased or used.
TherapeuticsMD announced the launch of newly reformulated vitaMedMD RediChew Rx, a branded prescription prenatal vitamin, and Prena1 Chew, a generic prescription prenatal vitamin.
Essentialis announced that the FDA has granted orphan drug designation to diazoxide choline, the active ingredient in DCCR for the treatment of Prader-Willi syndrome.
- Recall of Two IV Antibiotics Announced
- Peanut Allergy Patch Shows Promise in Latest Study
- Five Things ID Experts Want You to Know Before You Prescribe an Antibiotic
- What's Changed in Immunization Recommendations From CDC Advisory Committee
- Why Food Additives May Increase Risk of Inflammatory Diseases
- Limit Daily Use of Headphones, Warns WHO
- Sleep Deprivation Could Derail Healthy Eating Habits
- Not Enough COPD Patients Receiving Maintenance Tx, Research Suggests
- Harvoni for HCV Genotype 4, HIV Co-Infection Assessed in New Research
- Combo Therapy for HCV, HIV Co-Infection: New Data on Sustained Virologic Response